AVAC: Global Advocacy for HIV Prevention : EventList

MTN 2012 Regional Meeting

Sat, 29 Sep 2012 00:00:00 CDT

The 2012 MTN Regional Meeting will take place at the Westin Cape Town Hotel, Cape Town, South Africa, September 29-October 4, 2012.

AIDS 2012 Conference

Sun, 22 Jul 2012 00:00:00 CDT

The AIDS 2012 programme will present new scientific knowledge and offer many opportunities for structured dialogue on the major issues facing the global response to HIV.

The Fifth MSM Pre-Conference Event to the International AIDS Conference

Sat, 21 Jul 2012 09:00:00 CDT

The MSMGF is organizing the fifth MSM Pre-Conference Event to the International AIDS Conference, to be held in Washington, DC in July, 2012.

Controlling the HIV Epidemic with Antiretrovirals

Mon, 11 Jun 2012 00:00:00 CDT

The International Association of Physicians in AIDS Care (IAPAC) invites you to an evidence summit featuring the presentation of data related to and discussion about the implementation of treatment as prevention (TasP) and pre-exposure prophylaxis (PrEP) in clinical settings.

HIV/AIDS Update: Prevention, Treatment and Beyond

Fri, 11 May 2012 08:30:00 CDT

This one-day symposium will cover a broad spectrum of the latest developments in the prevention of HIV transmission and towards finding a cure for AIDS.

Microbicides 2012

Sun, 15 Apr 2012 00:00:00 CDT

The 2012 international Microbicides Conference (M2012) features state of the art plenary lectures on HIV prevention research, cross-disciplinary symposia on microbicides and other HIV prevention research, oral abstracts, and poster sessions.

2012 Keystone Symposia on HIV Vaccines

Wed, 21 Mar 2012 00:00:00 CDT

The 2012 Keystone Symposia meeting on HIV Vaccines will focus on basic aspects of immunology and HIV-1 virology to highlight issues that challenge the field.

Webinar: Rectal microbicide research update - MTN 007 and MTN 017

Thu, 15 Mar 2012 10:00:00 CDT

Dr. Ian McGowan will share just released results from the MTN 007 trial. Dr. Ross Cranston will discuss the upcoming MTN 017 trial.

Webinar: Exploring the new PrEP data from the CROI Conference

Tue, 13 Mar 2012 10:00:00 CDT

Additional data from a number of PrEP trials were presented at the 2012 Conference on Retroviruses and Opportunistic Infections. Please join fellow advocates and researchers from the FEM-PrEP and Partners PrEP trial teams to discuss the new data from these studies and others.

19th Conference on Retroviruses and Opportunistic Infections

Mon, 05 Mar 2012 00:00:00 CST

CROI 2012 took place from March 5-8, 2012 at the Washington State Convention Center in Seattle, Washington.

Webinar: Navigating the FDA review process

Wed, 29 Feb 2012 00:00:00 CST

This webinar was designed as an advocates' guide to the US Food and Drug Administration (FDA) review of data regarding TDF/FTC (Truvada) for HIV prevention. US-based advocates discussed steps for involvement in the process.

Global Teleconference: WHO recommendations on hormonal contraceptives and HIV

Thu, 23 Feb 2012 00:00:00 CST

The teleconference featured representatives from the WHO, UNAIDS, program implementers and civil society representatives who participated in the technical consultation.

Are We Ready to End AIDS? Community Forum

Wed, 22 Feb 2012 19:30:00 CST

This forum will bring together community leaders, organizations, advocates and people living with HIV to discuss the commitment to end AIDS in New York City. In light of the challenges & changes in the HIV/AIDS epidemic, we need to promote a common vision to respond to the health needs of our communities.

MTN 2012 Annual Meeting

Sat, 18 Feb 2012 00:00:00 CST

The MTN Annual Meeting has been scheduled for February 18-23, 2012 in North Bethesda, MD.

Global Webinar: The Impact of Treatment as Prevention -- Models to Guide Ending the Epidemic

Thu, 26 Jan 2012 00:00:00 CST

This webinar featured a presentation by Dr. John Blandford and discussion of the impact of expanded antiretroviral treatment on the AIDS epidemic in specific settings.

2012 National AAMSM Leadership Conference on HIV/AIDS

Thu, 19 Jan 2012 00:00:00 CST

This year's theme is "Forward Together '" Engaging Our Future Leaders".

2nd International Workshop on HIV & Women

Mon, 09 Jan 2012 00:00:00 CST

The workshop will gather a cross-disciplinary team of experts and trainees involved in research on HIV and Women, in order to present and discuss the latest developments and strategies for the future, in an interactive and science - focused setting.

2011 Research In Action Awards

Sun, 11 Dec 2011 18:00:00 CST

TAG's annual Research in Action Awards (RIAA) honors activists, scientists, philanthropists, and creative artists who have made extraordinary contributions in the fight against AIDS.

Moving Forward: Getting to Zero

Thu, 08 Dec 2011 17:00:00 CST

A panel discussion, interactive brainstorm and reception with leaders in the many realms of the fight against HIV/AIDS

16th International Conference on AIDS and Sexually Transmitted Infections in Africa (ICASA)

Sun, 04 Dec 2011 00:00:00 CST

Ethiopia will be hosting the 16th International Conference on AIDS and Sexually Transmitted Infections in Africa (ICASA) from 4-8 December 2011, under the theme "OWN, SCALE-UP and SUSTAIN." ICASA is one of the major international AIDS conferences happening in Africa. Its current biennial hosting alternates between the Anglophone and Francophone African countries.

Registration for the conference opens on the 3rd of January 2011 and closes by...

Global Advocates' Teleconference: VOICE trial update

Mon, 28 Nov 2011 00:00:00 CST

A call to discuss the VOICE trial DSMB recommending that the 1% tenofovir gel arm of the study be stopped and that the women in that arm exit the trial in a structured process.

2011 United States Conference on AIDS

Thu, 10 Nov 2011 00:00:00 CST

The United States Conference on AIDS (USCA) is the largest AIDS-related gathering in the U.S., bringing together over 3,000 workers from all fronts of the HIV/AIDS epidemic.

Global Teleconference on Hormonal Contraceptives and HIV

Thu, 20 Oct 2011 00:00:00 CDT

A global advocates' teleconference took place to provide an opportunity for advocates, researchers and policy makers to discuss and ask questions about recently published data on the relationship between hormonal contraceptive use and risk of HIV infection.

What We Know About PrEP & What's "Next"

Tue, 18 Oct 2011 18:00:00 CDT

A community forum to discuss "What We Know About PrEP & What's 'Next'" in the use of HIV medications as a prevention tool to reduce the risk of HIV infection.

Where:
LGBT Center
208 West 13th St

Presentation by:
Roy Gulick, MD, MPH
Professor of Medicine, Chief of the Division of Infectious Diseases,...

National Webinar for Young Black Gay Leadership

Fri, 14 Oct 2011 15:00:00 CDT

The National Black Gay Men's Advocacy Coalition (NBGMAC), co-sponsored by FHI 360 invites young Black Gay, Bisexual, and Same Gender Loving men from across the country to participate in a national webinar to develop solutions for addressing the HIV/AIDS epidemic within the young Black Gay, Bisexual, and Same Gender Loving community.

6th EDCTP Forum

Sun, 09 Oct 2011 00:00:00 CDT

The Sixth EDCTP Forum provides an international platform for the presentation and discussion of frontier research for everyone involved in combating the three main poverty-related diseases of HIV/AIDS, tuberculosis and malaria, and the appropriate capacity development and networking activities.

Global Teleconference: VOICE Trial Update

Fri, 30 Sep 2011 09:00:00 CDT

The VOICE trial team announced that the oral tenofovir pill arm of this five-arm study will close. To discuss these results with trial investigators and other key resource people, advocates were invited to join this global teleconference.

AIDS Vaccine Conference 2011

Mon, 12 Sep 2011 00:00:00 CDT

AV2011 will provide an interactive forum for the participation of leaders and future leaders in the HIV vaccine field'"policymakers and funders, multidisciplinary and highly specialized researchers, promising and talented young scientists, public-health experts, clinicians, epidemiologists, representatives of community associations and community advocates, and members of the private HIV vaccine-development sector'"thereby fostering and strengthening a collaborative global network and a global...

Safety Issues in Pre-Exposure Prevention in HIV Negative Individuals

Fri, 19 Aug 2011 00:00:00 CDT

Safety issues in pre-exposure prevention in HIV negative individuals, pros and cons of remedies that address safety concerns and public health implications.

2011 National HIV Prevention Conference

Sun, 14 Aug 2011 00:00:00 CDT

The 2011 National HIV Prevention Conference will bring together more than 3,000 individuals who are working to stop the spread of HIV in the United States. The theme of the 2011 National HIV Prevention Conference is: "The Urgency of Now: Reduce incidence. Improve access. Promote equity."

6th IAS Conference on HIV Pathogenesis, Treatment and Prevention

Sun, 17 Jul 2011 18:00:00 CDT

The IAS Conference on HIV Pathogenesis, Treatment and Prevention has a program that includes many sessions on a range of HIV-related topics. AVAC has compiled a roadmap that includes the range of HIV prevention research-related sessions planned for the conference.

2011 National LGBTI Health Summit

Sat, 16 Jul 2011 00:00:00 CDT

The 2011 National LGBTI Health Summit is dedicated to preserving and improving the emotional, physical, spiritual, mental, and social health and wellness of LGBTI people, who continue to experience significant health disparities because of our sexual orientations and/or gender identities.

Global Call to Discuss New Data from Partners PrEP and TDF2 PrEP Trials

Thu, 14 Jul 2011 07:00:00 CDT

Researchers from two different studies of oral pre-exposure prophylaxis (PrEP) announced evidence that both oral tenofovir (TDF, marketed as Viread) and oral tenofovir plus emtricitabine (TDF/FTC, marketed as Truvada) can reduce the risk of HIV transmission among men and women whose primary route of HIV exposure is penile-vaginal sex. These landmark findings, which came from the Partners PrEP and CDC TDF2 trials, extend the benefit previously observed in gay men and...

19th Biennial Meeting of the International Society for Sexually Transmitted Diseases Research

Sun, 10 Jul 2011 00:00:00 CDT

From July 10 to 13, 2011, Québec City will host the 19th Biennial meeting of the International Society for Sexually Transmitted Diseases Research on the theme of 'From research to intervention: successes and challenges'.

Gay Men: Are We Ready for PrEP?

Tue, 28 Jun 2011 18:00:00 CDT

A community discussion on Pre-Exposure Prophylaxis (PrEP) as a new treatment-based, HIV risk-reduction method for gay and bisexual men who are HIV-negative.

Rectal Microbicides 101: some Basics for MSM to Know

Wed, 15 Jun 2011 09:00:00 CDT

Join MSMFG and IRMA as Kadiri Audu, Lagos-based social worker and head of the Nigerian chapter of IRMA, discusses the basics of rectal microbicides that MSM need to know, with a special focus on experience working with MSM in Africa.

1st International HIV Social Science and Humanities Conference

Sat, 11 Jun 2011 00:00:00 CDT

This is the first international conference aimed at discussing and supporting contributions of the social sciences and humanities to HIV research and action.

March to End AIDS

Wed, 08 Jun 2011 11:00:00 CDT

June 8th is the first day of the High Level Meeting on HIV/AIDS. World Leaders will gather to announce their commitments to fight global AIDS. We need you to demand that they keep their promise to achieving universal access to treatment. We now know that this will end AIDS.

5th South African AIDS Conference

Tue, 07 Jun 2011 00:00:00 CDT

The upcoming South African AIDS Conference (7-10 June, 2011 at the International Conference Center in Durban) will feature a number of biomedical prevention research-related events. We highlight a few of these, and AVAC events at the conference, below.

The START Study in Metro DC

Thu, 02 Jun 2011 18:00:00 CDT

Presentation and discussion for investigators, nurses and other study staff, study participants, community members, and all who are interested in learning more about an international study of when-to-start HIV meds.

Webinar: Leveraging advocacy opportunities for Cervical Cancer at the UN High Level Meeting on NCDs

Thu, 02 Jun 2011 10:00:00 CDT

This Webinar Panel will discuss what is needed to strengthen advocacy efforts for cervical cancer, in relation to the UN High Level Meeting (HLM) in September 2011. It offers a follow-up to a series of regional and global planning meetings on cervical cancer that have taken place over the last year.

6th International Conference on HIV Treatment and Prevention Adherence

Sun, 22 May 2011 00:00:00 CDT

The 6th International Conference on HIV Treatment and Prevention Adherence will provide a forum where the state-of-the-science for HIV treatment and biomedical prevention adherence research will be presented, discussed, and translated into evidence-based approaches.

HIV Vaccine Awareness Day Cattle Call Spectacular

Wed, 18 May 2011 22:00:00 CDT

Therapy Singers and performers will compete in the Vaccine-o-licious Cattle Call for $1,000.

HIV Vaccine Awareness Day 2011

Wed, 18 May 2011 00:00:00 CDT

HIV Vaccine Awareness Day is observed annually on May 18th. This year, we at AVAC are emphasizing the urgent need to change assumptions and raise awareness around AIDS vaccine research. The vaccine field is as energized as it has ever been with key next steps towards an AIDS vaccine happening as we speak. The materials we've developed are designed to help start or strengthen conversations with different audiences.

Cracking the Safe: Advances in HIV/AIDS Prevention and Treatment

Mon, 16 May 2011 09:00:00 CDT

This one-day symposium will cover a range of issues facing researchers working towards the development of an HIV / AIDS vaccine, presenting an update on current challenges and solutions.

Global Call for Advocates to Discuss Recent Developments in HPTN 052

Fri, 13 May 2011 10:00:00 CDT

Download a recording of the phone call (mp3). Summary notes are also available.

HPTN 052 is a large, multi-site, randomized trial designed to determine the effectiveness of two treatment strategies in preventing the sexual transmission of HIV in couples where one partner is...

Discussion with Global Advocates and Researchers on FEM-PrEP

Thu, 12 May 2011 09:00:00 CDT

In response to the decision to discontinue FEM-PrEP, GCM is coordinating a teleconference with African communities to help address some of the questions raised. Experts from the HIV prevention research and advocate community will participate in a discussion aimed to guide us as we move forward in our search for HIV prevention tools for women in Africa.

Multipurpose Prevention Technologies for Reproductive Health

Thu, 05 May 2011 00:00:00 CDT

On May 5, 2011, the US Agency for International Development (USAID), Coalition Advancing Multipurpose Innovations (CAMI), and Global Advocacy for HIV Prevention (AVAC) convened a small group of scientists with expertise in contraception, HIV and STI prevention, vaccines, and devices to discuss and recommend practical strategies for accelerating the development of multipurpose prevention technologies (MPTs) for simultaneous protection against unintended pregnancy, HIV, and other...

Sparking Innovation to Save Lives

Tue, 03 May 2011 11:30:00 CDT

This event will highlight the role of research, science, and innovation in meeting US global health and development objectives. A high-level panel will speak about some key policy issues most critical to advancing research and science to meet the future needs of the developing world.

ARV-Prevention Webinar: Pill versus gel and rectal microbicide update

Mon, 25 Apr 2011 15:00:00 CDT

Please join IRMA and AVAC for a webinar that will provide an up-close look at important new microbicide data of relevance for prevention advocates. Peter Anton of UCLA and Craig Hendrix of Johns Hopkins University will review the findings they presented at the recent 18th Conference on Retroviruses and Opportunistic Infections in Boston.

PrEP Update: Webinar and FDA Sign-On Letter

Wed, 20 Apr 2011 15:30:00 CDT

The HIV PJA has been working hard this year to create a forum for open and honest discussion of the research and roll-out of Pre-Exposure Prophylaxis (PrEP).

Global Call to Discuss Discontinuation of FEM-PrEP Trial and Steps Forward

Tue, 19 Apr 2011 10:00:00 CDT

This global teleconference is to discuss the announcement that FEM-PrEP, an effectiveness trial of oral pre-exposure prophylaxis (PrEP) in women, not continue.

Medications That Prevents HIV - A Community Discussion About Pre-exposure Prophylaxis (PrEP)

Tue, 12 Apr 2011 19:00:00 CDT

Community dialogue at Brothers Reaching Brothers: Would you take HIV medication if it prevented HIV?

IRMA Lube Safety Working Group Update

Mon, 04 Apr 2011 12:00:00 CDT

One-hour IRMA Lube Safety Working Group Call

Kaiser/CSIS Forum with South African Minister of Health

Tue, 29 Mar 2011 12:00:00 CDT

The Henry J. Kaiser Family Foundation and the Center for Strategic and International Studies (CSIS) will host a forum with the South African Minister of Health, The Hon. Dr. Aaron Motsoaledi, on Tuesday, March 29 from noon to 2 p.m.

MTN 2011 Annual Meeting

Mon, 28 Mar 2011 00:00:00 CDT

The 2011 MTN Annual Meeting has been scheduled for March 28-31, 2011 at the Crystal Gateway Marriott, 1700 Jefferson Davis Highway, Arlington, VA 22202.

Keystone Symposia

Sun, 20 Mar 2011 00:00:00 CDT

The symposium is actually two conferences. The first is HIV Evolution, Genomics and Pathogenesis and the second is Protection from HIV: Targeted Intervention Strategies.

Accelerating an HIV Prevention Revolution: A Roadmap

Wed, 09 Mar 2011 12:00:00 CST

This amfAR Capitol Hill briefing will highlight:

Emerging scientific advances in HIV prevention research including recent findings about PrEP (a prevention pill), microbicides, vaccine development, and behavior change strategies
Innovative community models including “test and treat,” mapping viral load, and “treatment as prevention”
Opportunities for scaling up prevention programs...

ARV-based Prevention: A Community and Research Forum on Recent Results and What Happens Next

Tue, 01 Mar 2011 18:30:00 CST

Please join AVAC and Fenway Health in an open dialogue about recent ARV-based prevention results and their implications. This public forum welcomes those attending the Conference on Retroviruses and Opportunistic Infections as well as local stakeholders.

18th Conference on Retroviruses and Opportunistic Infections

Sun, 27 Feb 2011 00:00:00 CST

The 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011) is a scientifically focused meeting of the world's leading researchers working to understand, prevent, and treat HIV/AIDS and its complications.

Vaccines: The Best Shot For Our Health and Economy

Thu, 17 Feb 2011 12:00:00 CST

Vaccines: The Best Shot For Our Health and Economy will highlight both the economic and health impact that vaccines have, the lives they save, and the reason why an investment in the research and development of future vaccines is one of the most effective way to secure a healthier future globally and at home in the United States.

Translating PrEP Research into Practice

Tue, 08 Feb 2011 10:00:00 CST

The global teleconference, "Translating PrEP Research into Practice," featured debate and discussion with brief remarks from key discussants on what needs to happen next to translate the iPrEx trial results outside of clinical trial settings.

Lubricant Safety Update: Current Research and Advocacy Efforts

Mon, 24 Jan 2011 14:00:00 CST

This call covered the latest developments in lubricant safety research and advocacy. Speakers included Charlene Dezzutti of the Microbicide Trials Network, Pamina Gorbach of UCLA, and Marc-André LeBlanc, IRMA Secretary and resident lube advocacy expert (Jim Pickett filled in).

2011 National African American MSM Leadership Conference on HIV/AIDS & other Health Disparities

Thu, 20 Jan 2011 00:00:00 CST

NAESM and My Brother's Keeper of Jackson, MS will be co-sponsoring this year's National African American MSM Leadership Conference on HIV/AIDS & other Health Disparities.

1st International Workshop on HIV & Women

Mon, 10 Jan 2011 00:00:00 CST

iPrEx: What Next

Wed, 15 Dec 2010 00:00:00 CST

A community forum to discuss the iPrEX data and its potential impact on the future directon of Project PrEPare will take place in the Michael Leppen Theater at the Center on Halsted, 3656 N. Halsted, on Wednesday, December 15th 2010 from 6:30-8:30pm. The discussion will be co-facilitated by Jim Pickett, Director of Advocacy for the

A Pill to Prevent HIV: GCM Telebriefing for Global Advocates to Discuss iPrEx

Tue, 07 Dec 2010 10:00:00 CST

GCM will conduct a telebriefing joining experts from the science and advocacy community to discuss results from the first-ever study to show that a pill can help prevent HIV -- and what the results mean for women and men who have sex with men (MSM) in the global context.

Oral PrEP: Advantages and challenges in Canada

Mon, 06 Dec 2010 14:00:00 CST

CATIE, the Interagency Coalition on AIDS and Development, the Canadian AIDS Society and the Canadian Public Health Association will host a webinar session to review the concept of Oral Pre-Exposure Prophylaxis and the recently released results of the iPrEx trial and to discuss broader implications for Canadian communities.

Panel Discussion: Ending the Epidemic for Everyone: The Global Effort of HIV Vaccine and Prevention

Wed, 01 Dec 2010 00:00:00 CST

AVAC, in collaboration with Project Achieve, Columbia University Medical School and LGBT and Black and Latino Caucus student groups, will conduct a panel discussion.

World AIDS Day

Wed, 01 Dec 2010 00:00:00 CST

The World Health Organization established World AIDS Day in 1988 and is observed every year on December 1st. World AIDS Day provides governments, national AIDS programs, faith organizations, community organizations, and individuals with an opportunity to raise awareness and focus attention on the global AIDS epidemic.

HIV/AIDS in Asia: Is it a Rights Issue?

Wed, 01 Dec 2010 00:00:00 CST

To mark World AIDS Day, Asia Society and Asia Catalyst cordially invite you to HIV/AIDS in Asia: Is It a Rights Issue?, a discussion of key issues from the International AIDS Conference and explore their implications for Asia—where the prevalence of HIV continues to rise.

Panelist include:
Joseph...

World AIDS Day Meeting on HIV Vaccine Research

Tue, 30 Nov 2010 00:00:00 CST

The Global HIV Vaccine Enterprise will commemorate World AIDS Day during an event on advances in HIV vaccine research and development titled HIV Vaccines: Searching for Clues.

The event will be held at the Housing Works Bookstore Cafe and will feature updates from local experts and your opinions.

...

Women and Microbicides: What comes after the CAPRISA Trial?

Tue, 30 Nov 2010 00:00:00 CST

This event described the implications of and next steps following the CAPRISA 004 microbicide trial. Particular attention was given to women's vulnerability to HIV and the challenges of ensuring access to effective prevention products.

Advocates' Briefing on iPrEx PrEP Trial Results

Wed, 24 Nov 2010 00:00:00 CST

This webinar served as an opportunity for advocates to hear directly from the iPrEx trial team, including a number of the iPrEx trial principal investigators from around the world who joined the call. The 90-minute session included a short presentation of the results and a facilitated discussion which provided advocates with the opportunity to ask questions and discuss the implications of these results with the iPrEx trial team and colleagues.

...

"Can a pill a day prevent HIV?": Preparing for the results of the iPrEx PrEP study

Thu, 18 Nov 2010 00:00:00 CST

Conducted in partnership with The Desmond Tutu HIV Foundation, this webinar offered the opportunity to learn firsthand about the use of antiretrovirals for HIV prevention and explains the context, science and implications of the global iPrEx study.

Presented by members of the Cape Town iPrEx team:

Dr. Andrew Scheibe, Clinical Investigator
Ben Brown,...

All Eyes on Global iPrEx: An up-close look at the PrEP effectiveness study in MSM

Wed, 17 Nov 2010 00:00:00 CST

This webinar provided the opportunity to learn about how the iPrEx trial was designed and conducted, including discussion of how sites in Brazil, Ecuador, Peru, South Africa, Thailand and the US engaged and collaborated with gay men and other men who have sex with men.

Featured speaker: Pedro Goicochea, iPrEx investigator and communications and community relations...

Preparándose para los resultados de PrEP

Wed, 17 Nov 2010 00:00:00 CST

¿Qué?: Preparándose para los resultados de PrEP (presentado en español)
Presentación de Pedro Goicochea, investigador y comunicador sobre iPrEx y especialista en relaciones comunitarias

Contenido: Este seminario, el primero de la serie de AVAC/MSMGF presentado en español, ofrecerá información y antecedentes sobre la investigación de...

HVTN Conference

Sun, 14 Nov 2010 00:00:00 CST
The HIV Vaccine Trials Network (HVTN) full group meeting is now closed for registration. Visit http://www.hvtn.org/meeting/ for more details.

Primes and Boosts: How might ARV-based prevention and vaccines work better together?

Wed, 03 Nov 2010 00:00:00 CDT
This webinar will explore recent advances in ARV-based prevention research, its implications for future AIDS vaccine research and the opportunities and challenges for cooperation and integration in basic science, product development, product combinations, trial site infrastructure and clinical trial design...

Preparing for PrEP and Other ARV-based Prevention for MSM

Mon, 01 Nov 2010 00:00:00 CDT
Conducted in partnership with the Global Forum on MSM & HIV (MSMGF), this webinar provided background on PrEP, updates on research to date and identified key issues for advocates as we prepare for the upcoming results of iPrEx, the only PrEP effectiveness study in MSM. The iPrEx study is also the first PrEP trial that will report effectiveness results.

AIDS Alliance's call on maintain funding for school based HIV prevention (DASH)

Thu, 28 Oct 2010 04:00:00 CDT
AIDS Alliance is hosting a call about how to get informed/involved in the effort to maintain funding for school based HIV prevention (DASH). Over the past several months, DASH funded national partner organizations have been coordinating initiatives aimed at supporting DASH's resources through the annual Congressional appropriations process. During this conference call participants will discuss the current situation and provide resources, information and materials designed to encourage you to...

Cervical Cancer Action Webinar Series

Thu, 21 Oct 2010 00:00:00 CDT
Cervical Cancer Action is hosting a series of global webinars to bring the latest information and experience in global cervical cancer prevention to our members and friends. These events are accessible and free of charge to everyone. Please join us!

Third Annual Beth Waters Memorial Lecture

Tue, 12 Oct 2010 00:00:00 CDT
Beth Waters, a health care public relations specialist who passed away in 2006, had a great passion for vaccine advocacy to prevent and treat diseases worldwide. In commemoration of her crusading spirit, the Global Health Council presented the third annual Beth Waters Memorial Lecture by AVAC Executive Director, Mitchell Warren.

Open Forum: Give feedback on new Good Participatory Practice Guidelines

Tue, 05 Oct 2010 09:00:00 CDT
UNAIDS and AVAC invited stakeholders in biomedical HIV prevention research to join a webinar on the draft second edition of the Good Participatory Practice (GPP) Guidelines for biomedical HIV prevention trials.

AIDS Vaccine 2010

Fri, 01 Oct 2010 00:00:00 CDT
The annual AIDS Vaccine Conference took place in Atlanta, Georgia. This year marked its tenth anniversary of collaboration, education, and the exchange of scientific ideas, all with the purpose of advancing the science of HIV vaccines.

Visit the official AIDS Vaccine 2010 Conference...

The Basics of Drug Development Science '" Nothing to be scared of!

Wed, 29 Sep 2010 10:00:00 CDT
Enhance your advocacy skills and bone up on some of the basics. Jim Turpin of the Microbicide Research Branch at the National Institutes of Health, National Institutes of Allergy and Infectious Diseases, will explain the basic science of drug discovery '" the research that happens before we move on to Phase I safety testing in people. Many of us find basic science confusing, daunting, and scary. Jim will show us that it doesn't have to be any of those things, and is in fact, fascinating!

AIDS Vaccine 2010

Tue, 28 Sep 2010 00:00:00 CDT
The annual AIDS Vaccine Conference took place in Atlanta, Georgia. This year marked its tenth anniversary of collaboration, education, and the exchange of scientific ideas, all with the purpose of advancing the science of HIV vaccines.

Visit the official AIDS Vaccine 2010 Conference website.

AVAC and its partners were involved in a...

CHARMed - An update on the Combination HIV Antiretroviral Rectal Microbicide program

Tue, 14 Sep 2010 10:00:00 CDT
Join Ian McGowan, Principal Investigator, to learn about the status of CHARM - the Combination HIV Antitretrovial Rectal Microbicide Program - a 5-YEAR, $11 million project funded by the NIH.. The purpose of CHARM is to develop rectal-specific anitretroviral microbicides. Candidates include tenofovir, UC781, and a combination of tenofovir and UC781. Learn more in Section 2 of IRMA's report "From Promise to Product: Advancing Rectal Microbicide Research and Advocacy."

Sun, 12 Sep 2010 10:00:00 CDT
This lecture will highlight the road to accelerating the ethical development of AIDS vaccines through progress in research, policy analysis, advocacy and community mobilization. Key scientific, policy, social, ethical and economic challenges in vaccine development will also be discussed.

Emerging Issues in Today's HIV Response Debate Series: Discordant couples and HIV transmission

Thu, 26 Aug 2010 09:00:00 CDT
With leading donor countries emerging slowly from economic crisis, development aid flows are under heavy pressure. As a result, governments, development agencies, civil society organizations, communities of people living with HIV and AIDS, and other partners need the best evidence and knowledge available to make their development dollars go further in pursuit of better results. The World Bank’s Global HIV/AIDS Program and the Office of HIV/AIDS at USAID will co-host a series of debates...

Volunteers Needed for Education, HIV/AIDS awareness

Mon, 16 Aug 2010 08:15:00 CDT
We need volunteers in HIV/AIDS AWARENESS OUTREACH Spend time education communities and young people on HIV/AIDS and TB prevention. Visit schools and talk to students about good lifestyles. You will meet local people in communities and villages to sensitize them on the disease. Assist in local workshops, awareness seminars and support sessions. No Special skills required! Volunteers who have knowledge on HIV/AIDS and TB are highly encouraged to apply. However all volunteers for this...

XVIII International AIDS Conference (IAC)

Sun, 18 Jul 2010 00:00:00 CDT
The International AIDS Conference is a biennial meeting of the field that brings together nearly 25,000 activists, researchers, policymakers and government officials working in HIV/AIDS and related issues. The conference covers the plethora of issues facing the field, including a track that focuses on prevention science and research.

OCTAVE Workshop for Early Career Investigators on Good Participatory Practices

Sat, 17 Jul 2010 00:00:00 CDT
The OCTAVE Project (Online Collaborative Training for AIDS Vaccine Evaluation) and the Global HIV Vaccine Enterprise, in collaboration with AVAC and UNAIDS, are organizing an interactive workshop for Young and Early Career Investigators (YECIs). This workshop will focus on the process to engage community stakeholders in planning and conducting HIV biomedical prevention research. The GPP guidelines created by UNAIDS/AVAC will serve...

Webinar series on Microbicides 2010 Conference

Mon, 12 Jul 2010 00:00:00 CDT
This series of webinars based on thought-provoking presentations from the International Microbicides Conference (M2010) took place in June and July and provided advocates with a grounding in topics that were anticipated to emerge at the upcoming XVIII International AIDS Conference (IAC) in Vienna, July 18-23.

Webinar series on Microbicides 2010 Conference

Thu, 17 Jun 2010 00:00:00 CDT
This series of webinars based on thought-provoking presentations from the International Microbicides Conference (M2010) will take place in June and July and will provide advocates with a grounding in topics that may emerge at the upcoming XVIII International AIDS Conference (IAC) in Vienna, July 18-23.

IAVI Activities at the 37th Annual Global Health Conference

Mon, 14 Jun 2010 18:00:00 CDT
The International AIDS Vaccine Initiative will be participating in a number of events during this year's Global Health Conference , taking place June 14-18 at the Omni Shoreham Hotel in Washington D.C. If you are in the Washington D.C. area or are participating in the Conference, we hope you will join us.

AVAC at Microbicides 2010

Sat, 22 May 2010 18:00:00 CDT
AVAC posters presented at M2010 are available to download below:
Community Monitoring of the Rollout of Male Circumcision for HIV Prevention and its Implications for Women
Does PrEP need a Pipeline? Criteria for Identifying the Next PrEP...

2010 International Microbicides Conference (M2010)

Sat, 22 May 2010 00:00:00 CDT
The International Microbicides Conference is a biennial international gathering on microbicides. This year’s conference, with the theme of “Building Bridges in HIV Prevention”, featured updates and sessions on microbicides and the range of HIV prevention options currently being studied.

Additional details are available on the

Changing Course: Stemming the Deadly Twin Epidemics of HIV and Tuberculosis

Thu, 20 May 2010 00:00:00 CDT
As U.S. policymakers prepare to make key decisions about global health spending amid an unfolding crisis in access to HIV treatment in Africa, a group of the nation's leading scientists and advocates will gather to discuss the opportunities and challenges for combating the deadly dual epidemics of HIV and TB. Join Anthony Fauci, MD, director of NIH's National Institute of Allergy and Infectious Diseases and chief of the NIAID Laboratory of Immunoregulation; HIV scientist and clinician,...

6th Annual Vaccine-o-licious Show: performers uniting for an HIV vaccine

Wed, 19 May 2010 20:00:00 CDT

Glammy-award-winning Entertainer and Drag Queen of the Year, Peppermint, headlines this year’s sixth annual event as the newest Queen of Vaccine to promote HIV Vaccine Awareness Day. The event features “Broadway Hottie”

Symposium on HIV Vaccines and Alternate Treatment and Prevention Strategies

Wed, 19 May 2010 09:00:00 CDT
This meeting will tackle a range of challenges facing HIV vaccine researchers, and will counter each presented challenge with a possible solution. These challenges include development of HIV vaccines to prevent or control infection, genetic diversity of the virus, and predictive models of infection. The symposium will also cover other (non-scientific) challenges and mechanisms that can be used to reduce HIV transmission now, and in conjunction with a future...

HIV Vaccine Awareness Day 2010

Tue, 18 May 2010 00:00:00 CDT
Each year on May 18th, people around the world commemorate HIV Vaccine Awareness Day, an observance to recognize and thank the thousands of volunteers, community members, health professionals, researchers and scientists who are working together to find a safe and effective HIV vaccine. It is also a day to educate our communities about the importance of HIV vaccine research and development.

New Promise in the Search for HIV, TB and Malaria Vaccines

Mon, 17 May 2010 17:00:00 CDT

CAHR session: Prevention Technologies in the broader spectrum of HIV prevention

Thu, 13 May 2010 08:00:00 CDT
As part of the The 19th Annual Canadian Conference on HIV/AIDS Research - CAHR 2010 - this session will bring together community partners and Canadian researchers involved in basic and social sciences to explore how new HIV prevention technologies, including vaccines, microbicides and pre-exposure prophylaxis, fit within a broader continuum of HIV prevention strategies. The session will assess how existing and new prevention technologies can impact key populations, and discuss specific...

Let's Take Sexy Back! Sex Can Feel Good, and Be Safe Too...

Tue, 11 May 2010 00:00:00 CDT
While most safer sex and HIV prevention programmes are negative and disease-focused, The Pleasure Project is different: they take a positive, liberating and sexy approach to safer sex. Think of it as sex education ... with the emphasis on 'sex'. Join IRMA and The Pleasure Project's Anne Philpott for a global teleconference to take sexy back in our prevention work.

AIDS Research at NIH: New Opportunities to Change the Course of the Epidemic

Fri, 30 Apr 2010 12:00:00 CDT

amfAR, The Foundation for AIDS Research
AVAC
HIV Medicine Association
IDSA/HIVMA Center for Global Health Policy
San Francisco AIDS Foundation
Treatment Action Group
In collaboration with the office of Congresswoman Rosa DeLauro
and Congresswoman Barbara Lee invite you to a Congressional briefing

CHAMP Strategy Lab Call

Tue, 27 Apr 2010 13:00:00 CDT
Please join us for a lively discussion! Focus on Test-and-Treat...Treatment, Linkage to Care and Treatment (TLC+): Continuing the Community Dialogue

The HIV Research Catalyst Forum: Treatment, Prevention, Advocacy

Tue, 20 Apr 2010 00:00:00 CDT
The HIV Research Catalyst Forum: Treatment, Prevention, Advocacy (Formerly North American Treatment Action Forum—NATAF) is a conference focusing on community advocacy in HIV treatment and prevention research. From identifying research priorities to overcoming research barriers, HIV advocates have driven groundbreaking discoveries that have changed the course of this relentless epidemic. But with no cure...

Public Health Prostitution: Has AIDS Made Whores of Us All?

Wed, 14 Apr 2010 18:30:00 CDT
DePaul University's Social Science Research Center presents Public Health Prostitution: Has AIDS Made Whores of Us All?

Ask Elizabeth Pisani, author of The Wisdom of Whores: Bureaucrats, Brothels and the Business of AIDS, what she does for a living and she’ll say, “sex and drugs”. An epidemiologist specializing in HIV prevention, Elizabeth has...

AIDS Vaccine Development Series - Antiretrovirals for Prevention: Panacea or Pandora's Box

Wed, 14 Apr 2010 16:00:00 CDT
Dr. Kenneth Mayer will speak at the next IAVI Frontiers in AIDS Vaccine Development Seminar Series. The talk, Antiretrovirals for Prevention: Panacea or Pandora's Box?, will be held at the IAVI offices, 110 William Street, 27th Floor.

Public Forum: San Francisco General Hospital Plans to Treat All People Diagnosed with HIV

Tue, 13 Apr 2010 19:00:00 CDT
San Francisco public health officials have begun to offer patients newly diagnosed with HIV infection the opportunity to begin antiretroviral therapy (ART) immediately, rather than waiting until their CD4 cell count falls below the 350-500 cells/mm3 threshold in the current U.S. treatment guidelines. The controversial new policy will be discussed at a public forum in San Francisco on April 13.

The anal canal: an important transition zone for rectal microbicide development - AVAC and IRMA

Wed, 03 Mar 2010 00:00:00 CST
Dr. Ross Cranston discusses the normal anal canal, anal pathology, receptive anal intercourse and anal pathology, the anal canal in the context of HIV, and the potential importance of the anal canal in the context of microbicide development.

17th Conference on Retroviruses and Opportunistic Infections (CROI)

Tue, 16 Feb 2010 18:00:00 CST
The 17th Conference on Retroviruses and Opportunistic Infections (CROI 2010) is a scientifically focused meeting of the world's leading researchers working to understand, prevent, and treat HIV/AIDS and its complications. Visit the CROI roto website for more information on the conference program, registration and housing.

Epidemiology of HIV Among MSM in Africa: Implications for rectal microbicides - AVAC and IRMA

Wed, 27 Jan 2010 00:00:00 CST
Listen as Chris Beyrer MD, MPH, Professor at Johns Hopkins Bloomberg School of Public Health, presents on the sobering HIV data among MSM in Africa and discuss serious challenges such as the lack of access to water-based lubricants.

Advocates' briefing on results from the PRO 2000 microbicide MDP 301 study

Tue, 15 Dec 2009 08:00:00 CST
You are invited to join an Advocates' Tele-briefing hosted by the Global Campaign for Microbicides to discuss the key findings of MDP 301 on Tuesday 15 December 2009 at 9am DC/4pm Johannesburg. The Microbicides Development Programme (MDP) plans to announce the highly anticipated results of MDP 301 study testing the safety and effectiveness of 0.5% PRO 2000 on Monday, 14 December 2009. Leading MDP investigators will be available to share results from the study. You will have the opportunity to...

TAG's Annual Research in Action Awards

Sun, 13 Dec 2009 18:00:00 CST
TAG's Annual Research in Action Awards will be held on December 13th, 2009. The host for the 2009 RIAA Awards presentations is Jenna Wolfe, weekend anchor on NBC’s “Today Show.” For more information visit TAG's Save the Date webpage.

AAVP Forum: Building a Common Platform for HIV Prevention Research in Africa

Sun, 13 Dec 2009 00:00:00 CST
The African AIDS Vaccine Programme's 5th international forum will take place in Kampala, Uganda on December 13-15, 2009. This forum will convene a wide range of stakeholders in order to ensure strong linkages and collaboration and to provide important updates on a field that is constantly evolving.

This fifth forum will be a significant event as the AAVP moves toward a new paradigm of being headquartered in Africa.

Community Perspectives on iPrEP Research: An Interactive Discussion of Issues & Opinions

Wed, 09 Dec 2009 12:00:00 CST
This teleconference is a continuation of the intermittent pre-exposure prophylaxis (iPrEP) conversation being organized by the Research Working Group of the PrEP Committee. Organizers hope it will provide a forum for community members to express their thoughts and opinions on iPrEP research. To learn more about iPrEP and where to get background information read our Advocates' Network posting.

Efficacy and Effectiveness - What is Good Enough? Who decides?

Fri, 04 Dec 2009 10:00:00 CST
Join AVAC, Global Campaign for Microbicides and IRMA for a discussion about efficacy and effectiveness of new prevention technologies. The call will be held on Friday, December 4th at 10:00am US Eastern time.
RSVP for Efficacy and Effectiveness - What is Good Enough? Who decides?

Don't Waste Your WAD (World AIDS Day): Come get the 411 on new HIV prevention options

Wed, 02 Dec 2009 00:00:00 CST
The event is targeted toward black gay men and other MSM of color. Various presenters will discuss the array of experimental HIV prevention methods currently in research. The primary focus, however, will be on vaccines, including the recent Thai Prime Boost trial and the current 505 trial. Food and refreshments will be provided. Organizers: Project Achieve, AVAC, HVTN, Columbia University Medical Center, Gay Men of African Descent

Out of the Darkness: WAD candlelight vigil and gathering

Tue, 01 Dec 2009 18:00:00 CST
Candlelight vigil and procession begins at 6pm at the Trinity Lutheran Church and ends at the Broadway United Church of Chris (2504 Broadway, at 93rd St). At 6:30 there will be a time of reflection and reading of names of those we have lost to AIDS begins. The evening wraps up with a Worlds AIDS Day gathering at 7pm. Procession to Broadway United Church of Christ 2504 Broadway (at 93rd St) NYC

Cosponsors: ACT-UP New York, American Run for the End of AIDS, Broadway...

World AIDS Day in New York City

Tue, 01 Dec 2009 16:00:00 CST
AVAC, IAVI and the Global HIV Vaccine Enterprise, invite you to a symposium to explore recent progress and future directions in AIDS vaccine research and development. Refreshments will be provided. Check out the flier for the event for more information.

World AIDS DAY Luncheon: HIV Vaccine Research

Tue, 01 Dec 2009 12:00:00 CST
Free World AIDS Day Luncheon. This event will discuss current HIV vaccine research including the results of the 'Thai Study', and outcomes of the recent Paris HIV Vaccine Conference. Speakers will be announced shortly. The Luncheon event is free and open to the public. It will be held on December 1st, 2009, from 12:00 Noon to 2:00 PM at HRC Equality Center, 1640 Rhode Island Ave, NW.

World AIDS Day

Tue, 01 Dec 2009 00:00:00 CST
The World Health Organization established World AIDS Day in 1988 and is observed every year on December 1st. World AIDS Day provides governments, national AIDS programs, faith organizations, community organizations, and individuals with an opportunity to raise awareness and focus attention on the global AIDS epidemic. The World AIDS Day theme for 2009 is 'Universal Access and Human Rights'.

View this event for a listing of World AIDS Day events around the globe.

HVTN Conference

Tue, 17 Nov 2009 00:00:00 CST
The National HIV Vaccines Trials Network (HVTN) Conference will be held November 17-19 at the Grand Hyatt Seattle. For more information visit http://www.hvtn.org/meeting/.

Be Careful What You Wish For: What if PrEP works? Session 4 at USCA

Sat, 31 Oct 2009 00:00:00 CDT
As part of the United States Conference on AIDS (USCA), AVAC will be organizing a round table discussion entitled Be Careful What You Wish For: What if PrEP works? during Session 4: 8:30 AM - 10:30 AM, Saturday, October 31, 2009 in Union Square 13, Fourth Floor, in the Hilton San Francisco

United States Conference on AIDS (USCA)

Thu, 29 Oct 2009 00:00:00 CDT
The United States Conference on AIDS (USCA), will be held October 29-31, 2009, at the Hilton San Francisco Hotel (Union Square), in San Francisco, California. Over 3,000 AIDS professionals are expected to convene to build national support networks, exchange information and learn cutting- edge tools to address the challenges of HIV. For more information visit the National Minority AIDS Council website.

AIDS Vaccine 2009

Thu, 22 Oct 2009 00:00:00 CDT
This year's AIDS Vaccine Conference'"an annual gathering of researchers, funders and advocates to discuss the state of the field, new research discoveries and priorities for the year ahead'"was held in Paris. Click the title of this meeting to view information on this year's conference and a pre-conference satellite symposium.

AIDS Vaccine 2009

Thu, 22 Oct 2009 00:00:00 CDT
Tthe French National Agency for Research on AIDS and Viral Hepatitis (ANRS) and the Global HIV Vaccine Enterprise are honoured and pleased to welcome you back to Paris for the AIDS Vaccine Conference 2009, which will be held at the Marriott Rive Gauche Conference Center on the 19th to the 22nd of October 2009.

United States Conference on AIDS (USCA)

Mon, 28 Sep 2009 00:00:00 CDT
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum...

United States Conference on AIDS (USCA)

Sun, 27 Sep 2009 00:00:00 CDT
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum...

United States Conference on AIDS (USCA)

Sun, 30 Aug 2009 00:00:00 CDT
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum...

Preparing for PrEP: A Stakeholder's Dialogue

Sun, 23 Aug 2009 00:00:00 CDT
The UCLA Center for HIV Identification, Prevention and Treatment Services (CHIPTS) and various partners convened a day-long dialogue in advance of the 2009 National HIV Prevention Conference (NHPC) to discuss PrEP research, the possible social and cultural implications of PrEP and also engaged in a conversation with local PrEP trial participants. The session served to introduce attendees to PrEP and several of the related issues that were discussed in greater detail during sessions at NHPC....

The Promise and Perils of ARV-Based Prevention: A Dialogue of Optimism & Informed Skepticism

Sun, 19 Jul 2009 00:00:00 CDT
AVAC and the International AIDS Society (IAS) co-organized a satellite session on ARV-based prevention at the IAS Conference on HIV Pathogenesis, Treatment and Prevention in Cape Town. The session, The Promise and Perils of ARV-Based Prevention: A Dialogue of Optimism & Informed Skepticism, discussed many of the implementation challenges that ARV-based prevention (PrEP among them) might face.

CROI 2009 Distance Learning Series

Thu, 19 Feb 2009 00:00:00 CST
CHAMP and AVAC worked with partners to bring the information and dialogue from 2009 Conference on Retroviruses and Opportunistic Infections (CROI) conference to a much broader audience.

AVAC Think Tank on PrEP Financing in the US

Wed, 14 Jan 2009 00:00:00 CST
Colleagues from multiple disciplines met for a one-day, AVAC-sponsored think tank examining how PrEP for HIV prevention might be funded or reimbursed through insurance mechanisms in the United States should it prove safe and effective. The think tank took forward discussions on PrEP implementation strategies by identifying key regulatory, legal and financial challenges to PrEP implementation.

AVAC Think-Tank on Intermittent Dosing of PrEP

Sat, 20 Dec 2008 00:00:00 CST
In December 2008, AVAC held a one-day think tank where colleagues from multiple agencies and research disciplines discussed key scientific questions to be addressed in evaluating the merits of future prevention research on intermittent use of pre-exposure prophylaxis ("iPrEP") for prevention of HIV.

Beyond the Clinical Trial: The role of social science, behavior, vaginal and rectal practices and th

Wed, 31 Dec 1969 18:00:00 CST
Beyond the Clinical Trial: The role of social science, behavior, vaginal and rectal practices and th

eUSOkvltmlA

Wed, 31 Dec 1969 18:00:00 CST
eUSOkvltmlA

TpAuEjlJBLpEidpRRTy

Wed, 31 Dec 1969 18:00:00 CST
TpAuEjlJBLpEidpRRTy

JwKqwReclkFAASnni

Wed, 31 Dec 1969 18:00:00 CST
JwKqwReclkFAASnni

nXmRlUZBsC

Wed, 30 Nov -1 00:00:00 CST
nXmRlUZBsC

pfdhgmemwWLEnVvU

Wed, 30 Nov -1 00:00:00 CST
pfdhgmemwWLEnVvU

IXmQcScLVCwfD

Wed, 30 Nov -1 00:00:00 CST
IXmQcScLVCwfD

dBZREsAEOaRgFJif

Wed, 30 Nov -1 00:00:00 CST
dBZREsAEOaRgFJif

ZkUUwJfxKDqAOaHHIJm

Wed, 30 Nov -1 00:00:00 CST
ZkUUwJfxKDqAOaHHIJm

RVSrlEsYjbnf

Wed, 30 Nov -1 00:00:00 CST
RVSrlEsYjbnf

ZOTpjZwSxwy

Wed, 30 Nov -1 00:00:00 CST
ZOTpjZwSxwy

egNWbgnxmbjPjC

Wed, 30 Nov -1 00:00:00 CST
egNWbgnxmbjPjC

YOOQZsEsYvHhSCsrDdO

Wed, 30 Nov -1 00:00:00 CST
YOOQZsEsYvHhSCsrDdO

GIQEBEZOhn

Wed, 30 Nov -1 00:00:00 CST
GIQEBEZOhn

rtJXdgnNHkJzQbhs

Wed, 30 Nov -1 00:00:00 CST
rtJXdgnNHkJzQbhs

zQZgKefzLwsb

Wed, 30 Nov -1 00:00:00 CST
zQZgKefzLwsb

xLqrMWNIzLidB

Wed, 30 Nov -1 00:00:00 CST
xLqrMWNIzLidB

qDrfAbuONK

Wed, 30 Nov -1 00:00:00 CST
qDrfAbuONK

My feedback

Fri, 25 Nov 2011 17:28:08 CST
My feedback

Great work

Fri, 25 Nov 2011 17:34:40 CST
Great work

My feedback

Fri, 25 Nov 2011 17:35:52 CST
My feedback

My feedback

Fri, 25 Nov 2011 17:57:53 CST
My feedback

My feedback

Fri, 25 Nov 2011 18:15:31 CST
My feedback

Thank you

Fri, 25 Nov 2011 18:38:18 CST
Thank you

Thank you

Fri, 25 Nov 2011 18:47:01 CST
Thank you

Thank you

Fri, 25 Nov 2011 18:47:02 CST
Thank you

Thank you

Fri, 25 Nov 2011 18:53:37 CST
Thank you

Thank you

Fri, 25 Nov 2011 18:53:42 CST
Thank you

Great work

Fri, 25 Nov 2011 18:55:09 CST
Great work

Thank you

Fri, 25 Nov 2011 19:10:17 CST
Thank you

Thank you

Fri, 25 Nov 2011 19:10:29 CST
Thank you

My feedback

Fri, 25 Nov 2011 20:04:56 CST
My feedback

My feedback

Fri, 25 Nov 2011 20:05:36 CST
My feedback

My feedback

Fri, 25 Nov 2011 21:04:03 CST
My feedback

Thank you

Fri, 25 Nov 2011 21:34:28 CST
Thank you

Great work

Fri, 25 Nov 2011 21:48:11 CST
Great work

Great work

Fri, 25 Nov 2011 21:53:09 CST
Great work

My feedback

Fri, 25 Nov 2011 22:32:16 CST
My feedback

Thank you

Fri, 25 Nov 2011 22:46:16 CST
Thank you

My feedback

Fri, 25 Nov 2011 23:03:35 CST
My feedback

My feedback

Fri, 25 Nov 2011 23:04:02 CST
My feedback

My feedback

Fri, 25 Nov 2011 23:11:43 CST
My feedback

Thank you

Fri, 25 Nov 2011 23:12:17 CST
Thank you

Great work

Fri, 25 Nov 2011 23:18:24 CST
Great work

Great work

Fri, 25 Nov 2011 23:48:05 CST
Great work

Great work

Fri, 25 Nov 2011 23:48:16 CST
Great work

Great work

Fri, 25 Nov 2011 23:48:27 CST
Great work

Great work

Fri, 25 Nov 2011 23:48:30 CST
Great work

My feedback

Sat, 26 Nov 2011 00:09:38 CST
My feedback

My feedback

Sat, 26 Nov 2011 00:10:17 CST
My feedback

My feedback

Sat, 26 Nov 2011 00:21:25 CST
My feedback

My feedback

Sat, 26 Nov 2011 00:21:27 CST
My feedback

Thank you

Sat, 26 Nov 2011 00:36:54 CST
Thank you

Thank you

Sat, 26 Nov 2011 00:43:33 CST
Thank you

Thank you

Sat, 26 Nov 2011 00:43:43 CST
Thank you

Thank you

Sat, 26 Nov 2011 01:32:05 CST
Thank you

My feedback

Sat, 26 Nov 2011 01:32:53 CST
My feedback

Thank you

Sat, 26 Nov 2011 02:01:03 CST
Thank you

Thank you

Sat, 26 Nov 2011 02:17:47 CST
Thank you

My feedback

Sat, 26 Nov 2011 02:29:42 CST
My feedback

My feedback

Sat, 26 Nov 2011 02:45:17 CST
My feedback

Great work

Sat, 26 Nov 2011 02:52:32 CST
Great work

Thank you

Sat, 26 Nov 2011 03:06:28 CST
Thank you

Thank you

Sat, 26 Nov 2011 03:07:34 CST
Thank you

My feedback

Sat, 26 Nov 2011 03:16:08 CST
My feedback

My feedback

Sat, 26 Nov 2011 03:28:54 CST
My feedback

My feedback

Sat, 26 Nov 2011 03:29:09 CST
My feedback

My feedback

Sat, 26 Nov 2011 03:48:15 CST
My feedback

Great work

Sat, 26 Nov 2011 04:01:50 CST
Great work

Great work

Sat, 26 Nov 2011 04:09:33 CST
Great work

Great work

Sat, 26 Nov 2011 04:44:05 CST
Great work

Great work

Sat, 26 Nov 2011 05:04:23 CST
Great work

My feedback

Sat, 26 Nov 2011 05:07:23 CST
My feedback

Great work

Sat, 26 Nov 2011 05:08:05 CST
Great work

My feedback

Sat, 26 Nov 2011 05:11:55 CST
My feedback

My feedback

Sat, 26 Nov 2011 05:12:05 CST
My feedback

My feedback

Sat, 26 Nov 2011 05:15:08 CST
My feedback

Great work

Sat, 26 Nov 2011 05:43:25 CST
Great work

Great work

Sat, 26 Nov 2011 05:43:35 CST
Great work

Thank you

Sat, 26 Nov 2011 06:02:43 CST
Thank you

Thank you

Sat, 26 Nov 2011 06:10:50 CST
Thank you

Thank you

Sat, 26 Nov 2011 06:35:58 CST
Thank you

Thank you

Sat, 26 Nov 2011 06:36:44 CST
Thank you

Great work

Sat, 26 Nov 2011 06:39:27 CST
Great work

Great work

Sat, 26 Nov 2011 06:51:48 CST
Great work

Thank you

Sat, 26 Nov 2011 07:02:50 CST
Thank you

My feedback

Sat, 26 Nov 2011 07:35:14 CST
My feedback

Great work

Sat, 26 Nov 2011 07:53:09 CST
Great work

Great work

Sat, 26 Nov 2011 07:59:00 CST
Great work

My feedback

Sat, 26 Nov 2011 08:22:46 CST
My feedback

My feedback

Sat, 26 Nov 2011 08:22:56 CST
My feedback

Thank you

Sat, 26 Nov 2011 08:36:12 CST
Thank you

Great work

Sat, 26 Nov 2011 09:28:31 CST
Great work

My feedback

Sat, 26 Nov 2011 09:45:32 CST
My feedback

Thank you

Sat, 26 Nov 2011 09:50:17 CST
Thank you

Thank you

Sat, 26 Nov 2011 10:10:57 CST
Thank you

My feedback

Sat, 26 Nov 2011 10:11:42 CST
My feedback

My feedback

Sat, 26 Nov 2011 10:32:12 CST
My feedback

My feedback

Sat, 26 Nov 2011 10:40:34 CST
My feedback

Great work

Sat, 26 Nov 2011 10:57:58 CST
Great work

Thank you

Sat, 26 Nov 2011 12:21:38 CST
Thank you

My feedback

Sat, 26 Nov 2011 12:27:30 CST
My feedback

Thank you

Sat, 26 Nov 2011 12:40:23 CST
Thank you

My feedback

Sat, 26 Nov 2011 12:44:36 CST
My feedback

Great work

Sat, 26 Nov 2011 12:55:13 CST
Great work

Great work

Sat, 26 Nov 2011 12:55:24 CST
Great work

Great work

Sat, 26 Nov 2011 13:24:47 CST
Great work

Great work

Sat, 26 Nov 2011 13:24:55 CST
Great work

My feedback

Sat, 26 Nov 2011 13:40:19 CST
My feedback

My feedback

Sat, 26 Nov 2011 13:40:44 CST
My feedback

My feedback

Sat, 26 Nov 2011 13:40:51 CST
My feedback

Thank you

Sat, 26 Nov 2011 13:56:28 CST
Thank you

Thank you

Sat, 26 Nov 2011 13:58:12 CST
Thank you

Thank you

Sat, 26 Nov 2011 14:04:07 CST
Thank you

Great work

Sat, 26 Nov 2011 14:23:11 CST
Great work

Great work

Sat, 26 Nov 2011 14:23:14 CST
Great work

My feedback

Sat, 26 Nov 2011 14:43:09 CST
My feedback

My feedback

Sat, 26 Nov 2011 14:47:20 CST
My feedback

My feedback

Sat, 26 Nov 2011 15:01:48 CST
My feedback

My feedback

Sat, 26 Nov 2011 15:03:35 CST
My feedback

Great work

Sat, 26 Nov 2011 15:15:56 CST
Great work

Thank you

Sat, 26 Nov 2011 15:21:45 CST
Thank you

Thank you

Sat, 26 Nov 2011 15:27:49 CST
Thank you

My feedback

Sat, 26 Nov 2011 15:47:27 CST
My feedback

Great work

Sat, 26 Nov 2011 15:53:45 CST
Great work

My feedback

Sat, 26 Nov 2011 15:53:47 CST
My feedback

My feedback

Sat, 26 Nov 2011 15:54:06 CST
My feedback

My feedback

Sat, 26 Nov 2011 16:00:48 CST
My feedback

Thank you

Sat, 26 Nov 2011 16:04:40 CST
Thank you

Thank you

Sat, 26 Nov 2011 16:32:22 CST
Thank you

Great work

Sat, 26 Nov 2011 16:53:35 CST
Great work

Great work

Sat, 26 Nov 2011 17:31:09 CST
Great work

My feedback

Sat, 26 Nov 2011 17:38:07 CST
My feedback

My feedback

Sat, 26 Nov 2011 18:03:52 CST
My feedback

My feedback

Sat, 26 Nov 2011 18:04:15 CST
My feedback

My feedback

Sat, 26 Nov 2011 18:11:42 CST
My feedback

My feedback

Sat, 26 Nov 2011 18:17:33 CST
My feedback

Thank you

Sat, 26 Nov 2011 18:28:58 CST
Thank you

Great work

Sat, 26 Nov 2011 18:32:30 CST
Great work

My feedback

Sat, 26 Nov 2011 18:50:23 CST
My feedback

My feedback

Sat, 26 Nov 2011 19:01:41 CST
My feedback

My feedback

Sat, 26 Nov 2011 19:01:59 CST
My feedback

Thank you

Sat, 26 Nov 2011 19:12:14 CST
Thank you

Thank you

Sat, 26 Nov 2011 19:12:25 CST
Thank you

Thank you

Sat, 26 Nov 2011 19:12:27 CST
Thank you

Thank you

Sat, 26 Nov 2011 19:13:48 CST
Thank you

Great work

Sat, 26 Nov 2011 19:29:37 CST
Great work

Great work

Sat, 26 Nov 2011 19:47:20 CST
Great work

Great work

Sat, 26 Nov 2011 19:47:35 CST
Great work

Great work

Sat, 26 Nov 2011 19:48:06 CST
Great work

My feedback

Sat, 26 Nov 2011 19:49:33 CST
My feedback

Thank you

Sat, 26 Nov 2011 20:21:33 CST
Thank you

Thank you

Sat, 26 Nov 2011 20:25:26 CST
Thank you

Thank you

Sat, 26 Nov 2011 20:42:13 CST
Thank you

Thank you

Sat, 26 Nov 2011 20:42:18 CST
Thank you

Thank you

Sat, 26 Nov 2011 20:42:34 CST
Thank you

Great work

Sat, 26 Nov 2011 20:58:12 CST
Great work

Thank you

Sat, 26 Nov 2011 21:10:51 CST
Thank you

Thank you

Sat, 26 Nov 2011 21:27:15 CST
Thank you

Thank you

Sat, 26 Nov 2011 21:41:21 CST
Thank you

Thank you

Sat, 26 Nov 2011 22:08:34 CST
Thank you

My feedback

Sat, 26 Nov 2011 22:30:37 CST
My feedback

Thank you

Sat, 26 Nov 2011 22:50:37 CST
Thank you

Thank you

Sat, 26 Nov 2011 23:09:27 CST
Thank you

My feedback

Sat, 26 Nov 2011 23:17:57 CST
My feedback

Thank you

Sat, 26 Nov 2011 23:36:53 CST
Thank you

My feedback

Sat, 26 Nov 2011 23:39:17 CST
My feedback

My feedback

Sat, 26 Nov 2011 23:50:36 CST
My feedback

Great work

Sun, 27 Nov 2011 00:02:12 CST
Great work

Great work

Sun, 27 Nov 2011 00:02:13 CST
Great work

My feedback

Sun, 27 Nov 2011 00:38:15 CST
My feedback

Thank you

Sun, 27 Nov 2011 00:41:55 CST
Thank you

Thank you

Sun, 27 Nov 2011 00:47:55 CST
Thank you

Thank you

Sun, 27 Nov 2011 00:47:58 CST
Thank you

My feedback

Sun, 27 Nov 2011 00:56:24 CST
My feedback

Thank you

Sun, 27 Nov 2011 01:06:30 CST
Thank you

Thank you

Sun, 27 Nov 2011 01:13:07 CST
Thank you

Thank you

Sun, 27 Nov 2011 01:46:00 CST
Thank you

My feedback

Sun, 27 Nov 2011 01:49:53 CST
My feedback

Thank you

Sun, 27 Nov 2011 01:57:40 CST
Thank you

Great work

Sun, 27 Nov 2011 02:15:03 CST
Great work

My feedback

Sun, 27 Nov 2011 02:27:33 CST
My feedback

My feedback

Sun, 27 Nov 2011 02:48:12 CST
My feedback

My feedback

Sun, 27 Nov 2011 02:48:13 CST
My feedback

My feedback

Sun, 27 Nov 2011 02:59:23 CST
My feedback

My feedback

Sun, 27 Nov 2011 03:00:01 CST
My feedback

Thank you

Sun, 27 Nov 2011 03:06:33 CST
Thank you

Great work

Sun, 27 Nov 2011 03:22:48 CST
Great work

Great work

Sun, 27 Nov 2011 03:27:54 CST
Great work

Great work

Sun, 27 Nov 2011 03:46:45 CST
Great work

Thank you

Sun, 27 Nov 2011 03:58:06 CST
Thank you

Thank you

Sun, 27 Nov 2011 03:58:19 CST
Thank you

Great work

Sun, 27 Nov 2011 04:04:57 CST
Great work

Great work

Sun, 27 Nov 2011 04:42:56 CST
Great work

Thank you

Sun, 27 Nov 2011 04:47:18 CST
Thank you

My feedback

Sun, 27 Nov 2011 04:59:35 CST
My feedback

My feedback

Sun, 27 Nov 2011 05:03:48 CST
My feedback

My feedback

Sun, 27 Nov 2011 05:09:19 CST
My feedback

My feedback

Sun, 27 Nov 2011 05:09:19 CST
My feedback

My feedback

Sun, 27 Nov 2011 05:53:17 CST
My feedback

Great work

Sun, 27 Nov 2011 05:54:25 CST
Great work

Great work

Sun, 27 Nov 2011 06:08:43 CST
Great work

Great work

Sun, 27 Nov 2011 06:34:55 CST
Great work

Thank you

Sun, 27 Nov 2011 06:40:25 CST
Thank you

Great work

Sun, 27 Nov 2011 06:42:17 CST
Great work

Thank you

Sun, 27 Nov 2011 07:55:38 CST
Thank you

Great work

Sun, 27 Nov 2011 08:06:01 CST
Great work

My feedback

Sun, 27 Nov 2011 08:13:26 CST
My feedback

My feedback

Sun, 27 Nov 2011 08:15:59 CST
My feedback

Thank you

Sun, 27 Nov 2011 08:38:53 CST
Thank you

My feedback

Sun, 27 Nov 2011 09:05:32 CST
My feedback

Thank you

Sun, 27 Nov 2011 09:07:11 CST
Thank you

Thank you

Sun, 27 Nov 2011 09:07:11 CST
Thank you

My feedback

Sun, 27 Nov 2011 09:15:27 CST
My feedback

Thank you

Sun, 27 Nov 2011 09:17:44 CST
Thank you

Thank you

Sun, 27 Nov 2011 09:35:01 CST
Thank you

Thank you

Sun, 27 Nov 2011 09:35:01 CST
Thank you

Great work

Sun, 27 Nov 2011 10:04:35 CST
Great work

Great work

Sun, 27 Nov 2011 10:17:41 CST
Great work

Thank you

Sun, 27 Nov 2011 10:21:55 CST
Thank you

Great work

Sun, 27 Nov 2011 10:29:44 CST
Great work

Great work

Sun, 27 Nov 2011 10:32:11 CST
Great work

Great work

Sun, 27 Nov 2011 10:32:14 CST
Great work

Thank you

Sun, 27 Nov 2011 10:42:59 CST
Thank you

Thank you

Sun, 27 Nov 2011 11:08:52 CST
Thank you

Great work

Sun, 27 Nov 2011 11:22:05 CST
Great work

Thank you

Sun, 27 Nov 2011 11:23:38 CST
Thank you

My feedback

Sun, 27 Nov 2011 11:41:46 CST
My feedback

My feedback

Sun, 27 Nov 2011 12:16:08 CST
My feedback

Thank you

Sun, 27 Nov 2011 12:29:00 CST
Thank you

My feedback

Sun, 27 Nov 2011 12:43:40 CST
My feedback

Thank you

Sun, 27 Nov 2011 13:20:41 CST
Thank you

Great work

Sun, 27 Nov 2011 13:42:28 CST
Great work

My feedback

Sun, 27 Nov 2011 13:59:04 CST
My feedback

My feedback

Sun, 27 Nov 2011 14:22:12 CST
My feedback

Thank you

Sun, 27 Nov 2011 14:36:36 CST
Thank you

Great work

Sun, 27 Nov 2011 14:42:19 CST
Great work

Great work

Sun, 27 Nov 2011 14:52:48 CST
Great work

Thank you

Sun, 27 Nov 2011 15:01:33 CST
Thank you

My feedback

Sun, 27 Nov 2011 15:07:01 CST
My feedback

My feedback

Sun, 27 Nov 2011 15:07:05 CST
My feedback

Great work

Sun, 27 Nov 2011 15:18:03 CST
Great work

Great work

Sun, 27 Nov 2011 15:37:01 CST
Great work

Great work

Sun, 27 Nov 2011 15:49:09 CST
Great work

My feedback

Sun, 27 Nov 2011 16:10:34 CST
My feedback

My feedback

Sun, 27 Nov 2011 16:12:32 CST
My feedback

My feedback

Sun, 27 Nov 2011 16:38:40 CST
My feedback

My feedback

Sun, 27 Nov 2011 16:38:45 CST
My feedback

My feedback

Sun, 27 Nov 2011 16:47:58 CST
My feedback

My feedback

Sun, 27 Nov 2011 16:49:04 CST
My feedback

My feedback

Sun, 27 Nov 2011 17:04:38 CST
My feedback

My feedback

Sun, 27 Nov 2011 17:06:28 CST
My feedback

My feedback

Sun, 27 Nov 2011 17:06:41 CST
My feedback

Thank you

Sun, 27 Nov 2011 17:16:38 CST
Thank you

Thank you

Sun, 27 Nov 2011 17:18:41 CST
Thank you

Great work

Sun, 27 Nov 2011 17:40:16 CST
Great work

Great work

Sun, 27 Nov 2011 17:46:50 CST
Great work

Great work

Sun, 27 Nov 2011 17:52:50 CST
Great work

My feedback

Sun, 27 Nov 2011 18:05:02 CST
My feedback

My feedback

Sun, 27 Nov 2011 18:05:10 CST
My feedback

Great work

Sun, 27 Nov 2011 18:29:52 CST
Great work

Thank you

Sun, 27 Nov 2011 18:43:19 CST
Thank you

Thank you

Sun, 27 Nov 2011 18:58:36 CST
Thank you

Great work

Sun, 27 Nov 2011 19:10:33 CST
Great work

Thank you

Sun, 27 Nov 2011 19:19:47 CST
Thank you

Great work

Sun, 27 Nov 2011 19:35:41 CST
Great work

My feedback

Sun, 27 Nov 2011 19:41:54 CST
My feedback

Thank you

Sun, 27 Nov 2011 19:58:10 CST
Thank you

Thank you

Sun, 27 Nov 2011 20:08:56 CST
Thank you

Thank you

Sun, 27 Nov 2011 20:09:09 CST
Thank you

Great work

Sun, 27 Nov 2011 20:10:39 CST
Great work

Great work

Sun, 27 Nov 2011 20:22:14 CST
Great work

My feedback

Sun, 27 Nov 2011 20:46:33 CST
My feedback

My feedback

Sun, 27 Nov 2011 20:49:05 CST
My feedback

Thank you

Sun, 27 Nov 2011 21:27:45 CST
Thank you

Thank you

Sun, 27 Nov 2011 21:30:24 CST
Thank you

Great work

Sun, 27 Nov 2011 21:35:17 CST
Great work

Thank you

Sun, 27 Nov 2011 21:40:19 CST
Thank you

Thank you

Sun, 27 Nov 2011 21:53:15 CST
Thank you

Thank you

Sun, 27 Nov 2011 21:53:24 CST
Thank you

My feedback

Sun, 27 Nov 2011 22:12:35 CST
My feedback

My feedback

Sun, 27 Nov 2011 22:41:23 CST
My feedback

My feedback

Sun, 27 Nov 2011 22:49:04 CST
My feedback

My feedback

Sun, 27 Nov 2011 22:54:31 CST
My feedback

Great work

Sun, 27 Nov 2011 22:57:55 CST
Great work

Great work

Sun, 27 Nov 2011 23:00:31 CST
Great work

Great work

Sun, 27 Nov 2011 23:15:40 CST
Great work

My feedback

Sun, 27 Nov 2011 23:23:58 CST
My feedback

Great work

Sun, 27 Nov 2011 23:48:46 CST
Great work

My feedback

Sun, 27 Nov 2011 23:55:55 CST
My feedback

My feedback

Mon, 28 Nov 2011 00:05:06 CST
My feedback

Thank you

Mon, 28 Nov 2011 00:05:20 CST
Thank you

Thank you

Mon, 28 Nov 2011 00:12:04 CST
Thank you

My feedback

Mon, 28 Nov 2011 00:16:24 CST
My feedback

My feedback

Mon, 28 Nov 2011 00:21:22 CST
My feedback

My feedback

Mon, 28 Nov 2011 00:21:34 CST
My feedback

My feedback

Mon, 28 Nov 2011 01:16:22 CST
My feedback

My feedback

Mon, 28 Nov 2011 02:13:18 CST
My feedback

My feedback

Mon, 28 Nov 2011 02:13:31 CST
My feedback

My feedback

Mon, 28 Nov 2011 02:39:07 CST
My feedback

My feedback

Mon, 28 Nov 2011 03:23:14 CST
My feedback

Great work

Mon, 28 Nov 2011 03:01:15 CST
Great work

My feedback

Mon, 28 Nov 2011 03:11:46 CST
My feedback

My feedback

Mon, 28 Nov 2011 03:57:28 CST
My feedback

Thank you

Mon, 28 Nov 2011 03:59:53 CST
Thank you

Great work

Mon, 28 Nov 2011 04:09:23 CST
Great work

Great work

Mon, 28 Nov 2011 04:09:28 CST
Great work

Thank you

Mon, 28 Nov 2011 04:15:47 CST
Thank you

Great work

Mon, 28 Nov 2011 04:19:23 CST
Great work

Thank you

Mon, 28 Nov 2011 04:25:27 CST
Thank you

Thank you

Mon, 28 Nov 2011 04:25:37 CST
Thank you

Great work

Mon, 28 Nov 2011 04:29:08 CST
Great work

Thank you

Mon, 28 Nov 2011 04:49:09 CST
Thank you

Thank you

Mon, 28 Nov 2011 04:49:14 CST
Thank you

Great work

Mon, 28 Nov 2011 05:04:19 CST
Great work

Thank you

Mon, 28 Nov 2011 05:22:00 CST
Thank you

Great work

Mon, 28 Nov 2011 05:26:08 CST
Great work

Great work

Mon, 28 Nov 2011 05:45:58 CST
Great work

Thank you

Mon, 28 Nov 2011 05:53:10 CST
Thank you

My feedback

Mon, 28 Nov 2011 05:59:55 CST
My feedback

My feedback

Mon, 28 Nov 2011 06:00:00 CST
My feedback

My feedback

Mon, 28 Nov 2011 06:00:23 CST
My feedback

Great work

Mon, 28 Nov 2011 06:41:27 CST
Great work

Great work

Mon, 28 Nov 2011 06:44:35 CST
Great work

Thank you

Mon, 28 Nov 2011 06:51:24 CST
Thank you

My feedback

Mon, 28 Nov 2011 07:03:17 CST
My feedback

Great work

Mon, 28 Nov 2011 07:26:23 CST
Great work

Great work

Mon, 28 Nov 2011 07:39:11 CST
Great work

Great work

Mon, 28 Nov 2011 07:39:15 CST
Great work

Great work

Mon, 28 Nov 2011 07:39:26 CST
Great work

Great work

Mon, 28 Nov 2011 07:39:28 CST
Great work

Thank you

Mon, 28 Nov 2011 07:48:52 CST
Thank you